Aspirin for the prevention of pre-eclampsia: where do we stand now?
Ylikorkala
O
O
Helsinki University Central Hospital, Department of Obstetrics and Gynecology, Finland.
D000037:Abruptio Placentae / Q000139:chemically induced; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D016032:Randomized Controlled Trials as Topic
D001241:Aspirin